# CCB-MCB LLC – FDA Inspection, Sep 27, 2018

Source: https://www.keypedia.com/records/fda_inspections/ccb-mcb-llc/9d2887e2-16ea-4dca-92ee-f7207492550e
Source feed: FDA_Inspections

> FDA inspection 1069251 of CCB-MCB LLC, September 27, 2018. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1069251
- Company Name: CCB-MCB LLC
- Inspection Date: 2018-09-27
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1176120 - 2022-07-22
- FDA Inspection 981774 - 2016-08-04
- [FDA Inspection 837334 - 2013-07-02](https://www.keypedia.com/records/fda_inspections/ccb-mcb-llc/6c9ce537-29f3-41ca-963a-9205335ffe8b)
- FDA Inspection 721891 - 2011-04-28

## Related Officers

- [Amy Kim](https://www.keypedia.com/people/amy-kim/eee8b97a-b9d0-4709-96dc-70dbadd3a6a4)

Company: https://www.keypedia.com/companies/ccb-mcb-llc/5287d852-6909-4503-8e75-8f4d511f6b0f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d